Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaPAPADIMITRAKOPOULOU, Vassiliki A; GINSBERG, Lawrence E; LIPPMAN, Scott M et al.Cancer. 2003, Vol 98, Num 10, pp 2214-2223, issn 0008-543X, 10 p.Article

Loss of E-cadherin and p27 expression is associated with head and neck squamous tumorigenesisMASSARELLI, Erminia; BROWN, Erika; TRAN, Ngoc K et al.Cancer. 2005, Vol 103, Num 5, pp 952-959, issn 0008-543X, 8 p.Article

OUTCOMES OF PATIENTS WITH TONSILLAR CARCINOMA TREATED WITH POST-TONSILLECTOMY RADIATION THERAPYYILDIRIM, Gokcen; MORRISON, William H; ROSENTHAL, David I et al.Head & neck. 2010, Vol 32, Num 4, pp 473-480, issn 1043-3074, 8 p.Article

Cyclin D1 genotype, response to biochemoprevention, and progression rate to upper aerodigestive tract cancerIZZO, Julie G; PAPADIMITRAKOPOULOU, Vassiliki A; HITTELMAN, Walter N et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 3, pp 198-205, issn 0027-8874, 8 p.Article

Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract : Role in response to chemoprevention and cancer developmentPAPADIMITRAKOPOULOU, Vassiliki A; IZZO, Julie; HONG, Waun K et al.Clinical cancer research. 2001, Vol 7, Num 10, pp 3127-3134, issn 1078-0432Article

Akt activation correlates with adverse outcome in tongue cancerMASSARELLI, Erminia; LIU, Diane D; LEE, J. Jack et al.Cancer. 2005, Vol 104, Num 11, pp 2430-2436, issn 0008-543X, 7 p.Article

Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesionsPAPADIMITRAKOPOULOU, Vassiliki A; LIU, Diane D; LI MAO et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 12, pp 1605-1610, issn 1055-9965, 6 p.Article

The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: Potential for decreased toxicity and combination with biologic therapyHERBST, Roy S; KHURI, Fadlo R; BLUMENSCHEIN, George JR et al.Cancer. 2002, Vol 95, Num 2, pp 340-353, issn 0008-543X, 14 p.Article

Randomized Trial of 13 -as Retinoic Acid Compared With Retinyl Palmitate With or Without Beta-Carotene in Oral PremalignancyPAPADIMITRAKOPOULOU, Vassiliki A; LEE, J. Jack; LIPPMAN, Scott M et al.Journal of clinical oncology. 2009, Vol 27, Num 4, pp 599-604, issn 0732-183X, 6 p.Article

Randomized, double-blind, placebo-controlled phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakiaMULSHINE, James L; ATKINSON, Jane C; LINNOILA, R. Ilona et al.Clinical cancer research. 2004, Vol 10, Num 5, pp 1565-1573, issn 1078-0432, 9 p.Article

Pilot Randomized Phase II Study of Celecoxib in Oral Premalignant LesionsPAPADIMITRAKOPOULOU, Vassiliki A; WILLIAM, William N; NATHAN, Cherie-Ann et al.Clinical cancer research. 2008, Vol 14, Num 7, pp 2095-2101, issn 1078-0432, 7 p.Article

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancerZINNER, Ralph G; FOSSELLA, Frank V; ZHISHEN YE et al.Cancer. 2005, Vol 104, Num 11, pp 2449-2456, issn 0008-543X, 8 p.Article

Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: Report of a randomized comparative trialKOMAKI, Ritsuko; JIN SOO LEE; ZINNER, Ralph G et al.International journal of radiation oncology, biology, physics. 2004, Vol 58, Num 5, pp 1369-1377, issn 0360-3016, 9 p.Article

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasiaRUDIN, Charles M; COHEN, Ezra E. W; PAPADIMITRAKOPOULOU, Vassiliki A et al.Journal of clinical oncology. 2003, Vol 21, Num 24, pp 4546-4552, issn 0732-183X, 7 p.Article